BioCatalystWatch
FULCWorkspace / FULC / OverviewCompany library
Fulcrum Therapeutics, Inc. logo

Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics, Inc. (FULC)

Website

Price
Market cap
Next catalyst2H 2027SLTE-2100 · Trial initiationSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

SLTE-2100

PACAP × VIP × CGRP

PreINDP1P2P3FilingApproved
Upcoming / outlook

SLTE-1009

PACAP × VIP

Upcoming / outlook

SLTE-1009

PACAP × VIP

Upcoming / outlook

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

SLTE-1009

PACAP × VIP

Upcoming / outlook

  • Timing and evidence

SLTE-2100

PACAP × VIP × CGRP

PreINDP1P2P3FilingApproved
Upcoming / outlook

SLTE-1009

PACAP × VIP

Upcoming / outlook

Other pipelines

SLTE-1009

PACAP × VIP

FTX-6274

EED

PreINDP1P2P3FilingApproved

History / paused

p38α/β MAPK

PreINDP1P2P3FilingApproved

EED

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

FULC PR & News

PR & News

FULC SEC archive